Neonatal Fc Receptor Inhibitor Therapeutics in Neuromuscular Disease

Journal article

Peer reviewed

Mustafa Jaffry, Daniel L. Menkes, Anam Shaikh, Kranthi Mandava, Om Kothari, Kazim Jaffry and Nizar Souayah

Journal of clinical neuromuscular disease, v 24(4), pp 188-198

01 Jun 2023

PMID: 37219862

Additional Links

CIDP

FcRn inhibition

GBS

inflammatory myositis

Clinical Trials

Myasthenia Gravis

1 Record Views

Title: Neonatal Fc Receptor Inhibitor Therapeutics in Neuromuscular Disease
Creators: Mustafa Jaffry - Rutgers New Jersey Medical School
Daniel L. Menkes - Oakland University
Anam Shaikh - Rutgers New Jersey Medical School
Kranthi Mandava - Rutgers New Jersey Medical School
Om Kothari - Department of Medicine, Drexel University College of Medicine., United States
Kazim Jaffry - Rutgers New Jersey Medical School
Nizar Souayah - Rutgers New Jersey Medical School
Publication Details: Journal of clinical neuromuscular disease, v 24(4), pp 188-198
Publisher: Ovid
Number of pages: 11
Resource Type: Journal article
Language: English
Academic Unit: College of Medicine
Scopus ID: 2-s2.0-85160021197
Other Identifier: 991022207157904721